Vanderbilt University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Vanderbilt University sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).
Vanderbilt University: 430 sponsored US clinical trials, 15 recruiting.
Vanderbilt University sponsors 430 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 343 completed. 42 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
Vanderbilt University ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
343 of 401 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
430 total, page 7 of 9
Role of Adenosine in the Release of VEGF and Cytokines
NCT00580905
Use of Dermal Matrix in Breast Reconstruction
NCT00692692
Validation of an Assay to Measure Cyclooxygenase-1 Activity
NCT00761891
Vanderbilt Pertussis Exposure Study: PEP in Vaccinated Healthcare Workers Following Pertussis Exposure
NCT00469274
Identifying High- and Low-Risk Heart Failure Patients in the Emergency Department (The Stratify Study)
NCT00508638
Autonomic Nervous System and Chronic Fatigue Syndrome
NCT00580619
Impact of Gastric Bypass Surgery on Risk of CVD in Type 2 Diabetes Mellitus
NCT00444392
Comparison of Ondansetron, Metoclopramide and Promethazine for the Treatment of Nausea and Vomiting in the Adult ED
NCT00655642
Renal Salt Handling in Postural Tachycardia Syndrome Following Dietary Dopa Administration
NCT01064739
QT Variability Pre and Post Cardioversion
NCT00885391
The Effect of Guided Imagery on the Third Stage of Labor
NCT00826735
Medication, Weight Gain and GI Hormones
NCT00384332
Expressive Writing in Improving Quality of Life in Patients With Breast Cancer and Lymphedema
NCT00679185
Characterization of Brachial Arterial t-PA Release, Endothelial Function, Obesity and Inflammation
NCT00780481
Characterizing PAI-1 Modulation on Monocyte Adhesion
NCT00512031
Post-operative Mobilization for Carpal Tunnel Syndrome
NCT00435149
Blood and Tissue Sample Collection for Future Colon Cancer Biomarker Studies in Patients Undergoing Colonoscopy
NCT00897403
Comparison of Central Versus Peripheral Placement of Local Anesthetic
NCT00699244
Correlating Clinical Disease State With Color Doppler Ultrasound
NCT00761943
Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics
NCT00581048
Improving Care for Primary Care Patients With Diabetes and Poor Literacy and Numeracy Skills
NCT00469105
Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
NCT00408525
The Effect of Surgical Incision Size on Carpal Tunnel Surgery
NCT00435071
Tennessee Connections for Better Birth Outcomes
NCT00502697
A Study to Determine Whether Urinary PGE-M Levels Correlate With Ulcerative Colitis Disease
NCT00409396
Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 1
NCT00574665
Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux
NCT00373997
The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications
NCT00603148
A Prospective Study of Radiation Exposure to Surgeons
NCT00378053
Thrombin Regulated Platelet Activation
NCT00855296
Interpretation of Transnasal Esophagoscopy Findings
NCT00372918
Progressive Splinting Status Post Elbow Fractures and Dislocations
NCT00580866
Efficacy of Lansoprazole in Chronic Post Nasal Drip
NCT00335283
Neurodevelopment and Neuroimaging in Parenterally-fed Infants and Young Children
NCT00392730
Prevalence of Spasticity in Adults With Mental Retardation Living in the Community
NCT00282191
Growth Hormone's Effect on Endothelial Progenitor Cells
NCT00397592
Acetyl-L-Carnitine in the Treatment of Septic Shock
NCT00592488
The RAS, Fibrinolysis and Cardiopulmonary Bypass
NCT00607672
Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors
NCT00625417
Brain Manganese Deposition in High Risk Neonates
NCT00392977
Protein Supplementation in Dialysis Patients
NCT00367198
Aspirin Resistance in Coronary Artery Disease
NCT00753935
Antioxidant Systems and Age-Related Macular Degeneration
NCT00668213
Unrelated Donor BMT for Treatment of Patients With PGK Deficiency
NCT00592540
Bradykinin Receptor Antagonism During Cardiopulmonary Bypass
NCT00223704
Self-Care for Lymphedema in Patients With Breast Cancer
NCT00670644
Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
NCT00608465
Provision of Antioxidant Therapy in Hemodialysis (PATH) Study
NCT00237718
Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease
NCT00368017
Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)
NCT00308971
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 50 |
| Phase 2 | 42 |
| Phase 3 | 10 |
| Phase 4 | 32 |
Therapeutic Areas
What is open in the Vanderbilt University pipeline
15 recruiting of 430 indexed (3% open); 343 completed (80%).
Phase mix: 42 late (III/IV) vs 92 early (I/II) (early-phase heavy).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Vanderbilt University: open-pipeline peers nationwide
Peers matched on 430 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
Vanderbilt University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 430 trials (± recruiting share)
- University of Illinois at Chicago · 430 trials · 27% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
- Dartmouth-Hitchcock Medical Center · 427 trials · 12% recruiting
Sponsors near 3% open enrollment (± trial volume)
- USDA Grand Forks Human Nutrition Research Center · 4% recruiting · 57 trials
- Medtronic MiniMed · 3% recruiting · 29 trials
- Sandoz · 3% recruiting · 29 trials
- Sonova · 3% recruiting · 29 trials
Related
What to do with this Vanderbilt University page
430 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University or any single study.
- 15 of Vanderbilt University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Vanderbilt University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Vanderbilt University pipeline card: 430 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.